Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04
Published September 27, 2017 · Recall initiated: August 22, 2017
Summary
FDA records drug Class II recall D-1168-2017, published September 27, 2017 and initiated August 22, 2017. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 98,050 vials; Lot: Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOPHED has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOPHED
- Manufacturer
- Pfizer Inc.
- Distributor
- United States Nationwide (including Puerto Rico) and Singapore
- Lot
- Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only,September 27, 2017
- FDADaytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30September 27, 2017
- FDAFentanyl Citrate (Preservative Free) 20 mcg per mL (2,000 mcg per 100 mL) 100 mL total volume in a 100 mLSeptember 27, 2017
- FDADaytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Rx Only Contains: 30September 27, 2017
- FDAFentanyl Citrate (Preservative Free) 10 mcg per mL (1,000 mcg per 100 mL) 100 mL total volume in a 100 mLSeptember 27, 2017
- FDALevophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest,June 21, 2017
Questions about this recall
Was Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04 recalled?
Yes. FDA published recall D-1168-2017 on September 27, 2017. Reported hazard: Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOPHED.